ketendoКлиническая и экспериментальная тиреоидологияClinical and experimental thyroidology1995-54722310-3787Endocrinology Research Centre10.14341/ket2016212-18ketendo-8158Research ArticleНовости мировой тиреоидологииNews of the world thyroidologyНовости мировой тиреодологииWorld thyroidology newsМануйловаЮлия АлександровнаManuylovaYulia A.

MD, PhD

juliakolish@yahoo.comМошенинаСофьяMosheninaSofia

MD

sonaga@yandex.ruАмосоваМарияAmosovaMariya V.

MD

mariaamosova@mail.ruФГБОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава РоссииРоссияFirst Moscow State Medical UniversityRussian Federation201602112016122Том 12, №2 (2016)1218Copyright © Мануйлова Ю.А., Мошенина С., Амосова М.V., 20162016Мануйлова Ю.А., Мошенина С., Амосова М.Manuylova Y.A., Moshenina S., Amosova M.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.cet-endojournals.ru/jour/article/view/8158

Представлены абстракты актуальных международных исследований, посвященных диагностике и лечению различной патологии щитовидной железы, а также влиянию на тиреоидную функцию сопутствующих состояний.

Abstracts of articles devoted to the most topical issues of thyroid pathology are provided. Influence of various associated diseases on thyroid function is considered, and the probability of emergence pathology various systems in case of the available thyroid diseases is studied. A part of articles is devoted to researches of such important subjects as quality of life patients with thyroid pathology  and cost efficiency of different types therapy. The works studying pathogenesis of thyroid diseases  are also included.

щитовидная железатерапия радиоактивным йодомвитамин Дтироксинсубклинический гипотиреозгиперпролактинемияthyroid gland131Iodine treatmentvitamin Dthyroxinesubclinical hypothyroidismhyperprolactinemiaReferencesDonovan P, McLeod D, Little R, Gordon L. Cost-utility analysis comparing radioactive iodine, antithyroid drugs and total thyroidectomy for primary treatment of Graves’ disease. Eur J Endocrinol.2016. doi: 10.1530/EJE-16-0527.Donovan P, McLeod D, Little R, Gordon L. Cost-utility analysis comparing radioactive iodine, antithyroid drugs and total thyroidectomy for primary treatment of Graves’ disease. Eur J Endocrinol.2016. doi: 10.1530/EJE-16-0527.Zhang LH, Li JY, Tian Q, et al. Follow-up and evaluation of the pregnancy outcome in women of reproductive age with Graves’ disease after 131Iodine treatment. J Radiat Res. 2016. doi: 10.1093/jrr/rrw049.Zhang LH, Li JY, Tian Q, et al. Follow-up and evaluation of the pregnancy outcome in women of reproductive age with Graves’ disease after 131Iodine treatment. J Radiat Res. 2016. doi: 10.1093/jrr/rrw049.Hiratsuka I, Yamada H, Munetsuna E, et al. Circulating microRNAs in Graves’ disease in relation to clinical activity. Thyroid. 2016. doi: 10.1089/thy.2016.0062.Hiratsuka I, Yamada H, Munetsuna E, et al. Circulating microRNAs in Graves’ disease in relation to clinical activity. Thyroid. 2016. doi: 10.1089/thy.2016.0062.Delitala AP, Steri M, Pilia MG, et al. Menopause modulates the association between thyrotropin levels and lipid parameters: The SardiNIA study. Maturitas. 2016;92:30-34. doi: 10.1016/j.maturitas.2016.07.003.Delitala AP, Steri M, Pilia MG, et al. Menopause modulates the association between thyrotropin levels and lipid parameters: The SardiNIA study. Maturitas. 2016;92:30-34. doi: 10.1016/j.maturitas.2016.07.003.Taieb D, Bournaud C, Eberle MC, et al. Quality of life, clinical outcomes and safety of early prophylactic levothyroxine administration in patients with Graves’ hyperthyroidism undergoing radioiodine therapy: a randomized controlled study. Eur J Endocrinol. 2016;174(4):491-502. doi: 10.1530/EJE-15-1099.Taieb D, Bournaud C, Eberle MC, et al. Quality of life, clinical outcomes and safety of early prophylactic levothyroxine administration in patients with Graves’ hyperthyroidism undergoing radioiodine therapy: a randomized controlled study. Eur J Endocrinol. 2016;174(4):491-502. doi: 10.1530/EJE-15-1099.Elfenbein DM, Schaefer S, Shumway C, et al. Prospective intervention of a novel levothyroxine dosing protocol based on body mass index after thyroidectomy. J Am Coll Surg. 2016;222(1):83-88. doi: 10.1016/j.jamcollsurg.2015.10.005.Elfenbein DM, Schaefer S, Shumway C, et al. Prospective intervention of a novel levothyroxine dosing protocol based on body mass index after thyroidectomy. J Am Coll Surg. 2016;222(1):83-88. doi: 10.1016/j.jamcollsurg.2015.10.005.Dorr HG, Bettendorf M, Binder G, et al. Levothyroxine treatment of euthyroid children with autoimmune Hashimoto thyroiditis: results of a multicenter, randomized, controlled trial. Horm Res Paediatr. 2015;84(4):266-274. doi: 10.1159/000437140.Dorr HG, Bettendorf M, Binder G, et al. Levothyroxine treatment of euthyroid children with autoimmune Hashimoto thyroiditis: results of a multicenter, randomized, controlled trial. Horm Res Paediatr. 2015;84(4):266-274. doi: 10.1159/000437140.Norlen O, Popadich A, Kruijff S, et al. Bethesda III thyroid nodules: the role of ultrasound in clinical decision making. Ann Surg Oncol. 2014;21(11):3528-3533. doi: 10.1245/s10434-014-3749-8.Norlen O, Popadich A, Kruijff S, et al. Bethesda III thyroid nodules: the role of ultrasound in clinical decision making. Ann Surg Oncol. 2014;21(11):3528-3533. doi: 10.1245/s10434-014-3749-8.Kiernan CM, Broome JT, Solorzano CC. The Bethesda system for reporting thyroid cytopathology: a single-center experience over 5 years. Ann Surg Oncol. 2014;21(11):3522-3527. doi: 10.1245/s10434-014-3743-1.Kiernan CM, Broome JT, Solorzano CC. The Bethesda system for reporting thyroid cytopathology: a single-center experience over 5 years. Ann Surg Oncol. 2014;21(11):3522-3527. doi: 10.1245/s10434-014-3743-1.Mazokopakis EE, Papadomanolaki MG, Tsekouras KC, et al. Is vitamin D related to pathogenesis and treatment of Hashimoto’s thyroiditis? Hell J Nucl Med. 2015;18(3):222-227.Mazokopakis EE, Papadomanolaki MG, Tsekouras KC, et al. Is vitamin D related to pathogenesis and treatment of Hashimoto’s thyroiditis? Hell J Nucl Med. 2015;18(3):222-227.Haddow JE, Craig WY, Neveux LM, et al. Free thyroxine during early pregnancy and risk for gestational diabetes. PLoS One. 2016;11(2):e0149065. doi: 10.1371/journal.pone.0149065.Haddow JE, Craig WY, Neveux LM, et al. Free thyroxine during early pregnancy and risk for gestational diabetes. PLoS One. 2016;11(2):e0149065. doi: 10.1371/journal.pone.0149065.Chiappa C, Rovera F, Rausei S, et al. Breast cancer and thyroid diseases: analysis of 867 consecutive cases. J Endocrinol Invest. 2016. doi: 10.1007/s40618-016-0543-4.Chiappa C, Rovera F, Rausei S, et al. Breast cancer and thyroid diseases: analysis of 867 consecutive cases. J Endocrinol Invest. 2016. doi: 10.1007/s40618-016-0543-4.Yilmaz Y, Kamer KE, Ureyen O, et al. The effect of preoperative Lugol’s iodine on intraoperative bleeding in patients with hyperthyroidism. Ann Med Surg (Lond). 2016;9:53-57. doi: 10.1016/j.amsu.2016.06.002.Yilmaz Y, Kamer KE, Ureyen O, et al. The effect of preoperative Lugol’s iodine on intraoperative bleeding in patients with hyperthyroidism. Ann Med Surg (Lond). 2016;9:53-57. doi: 10.1016/j.amsu.2016.06.002.Sharma LK, Sharma N, Gadpayle AK, Dutta D. Prevalence and predictors of hyperprolactinemia in subclinical hypothyroidism. Eur J Intern Med. 2016. doi: 10.1016/j.ejim.2016.07.012.Sharma LK, Sharma N, Gadpayle AK, Dutta D. Prevalence and predictors of hyperprolactinemia in subclinical hypothyroidism. Eur J Intern Med. 2016. doi: 10.1016/j.ejim.2016.07.012.Stan MN, Sonawane V, Sebo TJ, et al. Riedel’s thyroiditis association with IgG4-related disease. Clin Endocrinol (Oxf). 2016. doi: 10.1111/cen.13238.Stan MN, Sonawane V, Sebo TJ, et al. Riedel’s thyroiditis association with IgG4-related disease. Clin Endocrinol (Oxf). 2016. doi: 10.1111/cen.13238.

The authors declare that there are no conflicts of interest present.